DE69714971T2 - Verfahren zur herstellung von purin-derivaten - Google Patents

Verfahren zur herstellung von purin-derivaten

Info

Publication number
DE69714971T2
DE69714971T2 DE69714971T DE69714971T DE69714971T2 DE 69714971 T2 DE69714971 T2 DE 69714971T2 DE 69714971 T DE69714971 T DE 69714971T DE 69714971 T DE69714971 T DE 69714971T DE 69714971 T2 DE69714971 T2 DE 69714971T2
Authority
DE
Germany
Prior art keywords
purine derivatives
intermediates
producing purine
purin
propanediol
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69714971T
Other languages
English (en)
Other versions
DE69714971D1 (de
DE69714971T3 (de
Inventor
B Arzeno
D Axt
C Beard
A Dvorak
R Fatheree
E Fisher
Yeun-Kwei Han
R Humphreys
P Lund
Linh Nguyen
Leslie Wren
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
F Hoffmann La Roche AG
Original Assignee
F Hoffmann La Roche AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by F Hoffmann La Roche AG filed Critical F Hoffmann La Roche AG
Publication of DE69714971D1 publication Critical patent/DE69714971D1/de
Publication of DE69714971T2 publication Critical patent/DE69714971T2/de
Application granted granted Critical
Publication of DE69714971T3 publication Critical patent/DE69714971T3/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D473/00Heterocyclic compounds containing purine ring systems
    • C07D473/02Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6
    • C07D473/18Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 one oxygen and one nitrogen atom, e.g. guanine
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D473/00Heterocyclic compounds containing purine ring systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52Purines, e.g. adenine

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
DE69714971T 1996-01-26 1997-01-21 Verfahren zur herstellung von purin-derivaten Expired - Lifetime DE69714971T3 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US59207996A 1996-01-26 1996-01-26
US592079 1996-01-26
PCT/EP1997/000262 WO1997027198A1 (en) 1996-01-26 1997-01-21 Process for preparing purine derivatives

Publications (3)

Publication Number Publication Date
DE69714971D1 DE69714971D1 (de) 2002-10-02
DE69714971T2 true DE69714971T2 (de) 2003-05-28
DE69714971T3 DE69714971T3 (de) 2005-12-15

Family

ID=24369197

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69714971T Expired - Lifetime DE69714971T3 (de) 1996-01-26 1997-01-21 Verfahren zur herstellung von purin-derivaten

Country Status (10)

Country Link
JP (1) JP4094667B2 (de)
KR (1) KR100491941B1 (de)
CN (1) CN1064683C (de)
AT (1) ATE222909T1 (de)
AU (1) AU1543797A (de)
CA (1) CA2243650C (de)
DE (1) DE69714971T3 (de)
ES (1) ES2180923T5 (de)
MX (1) MX9805935A (de)
WO (1) WO1997027198A1 (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6703394B2 (en) 1996-02-16 2004-03-09 Medivir Ab Acyclic nucleoside derivatives
US5869493A (en) 1996-02-16 1999-02-09 Medivir Ab Acyclic nucleoside derivatives
JP2007505070A (ja) * 2003-09-11 2007-03-08 エフ.ホフマン−ラ ロシュ アーゲー 抗ウイルス性ヌクレオシド誘導体を製造する方法
ZA200702234B (en) * 2006-03-21 2008-07-30 Cipla Ltd Preparation of ester of purine derivatives
WO2012163373A1 (en) * 2011-05-31 2012-12-06 Pharmathen S.A. Process for the preparation of 2-amino-9-((2-phenyl-1,3-dioxan-5-yloxy)methyl)-1h-purin-6(9h)-one compound useful in the preparation of valganciclovir

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4816447A (en) * 1981-08-26 1989-03-28 Merck & Co., Inc. Anti-viral guanine compounds
NL8202626A (nl) * 1982-06-29 1984-01-16 Stichting Rega V Z W Derivaten van 9-(2-hydroxyethoxymethyl)guanine.
AP160A (en) * 1987-08-15 1991-11-18 The Wellcome Foundation Ltd Therapeutic acyclic nucleosides.
AU618436B2 (en) * 1988-12-19 1991-12-19 Wellcome Foundation Limited, The Antiviral cytosine and guanine derivatives
JP3225545B2 (ja) * 1991-09-18 2001-11-05 味の素株式会社 非環状ヌクレオシド類の製造法
PE32296A1 (es) * 1994-07-28 1996-08-07 Hoffmann La Roche Ester de l-monovalina derivado de 2-(2-amino-1,6-dihidro-6-oxo-purin-9-il) metoxi-1,3-propandiol y sus sales farmaceuticamente aceptables

Also Published As

Publication number Publication date
DE69714971D1 (de) 2002-10-02
CN1212693A (zh) 1999-03-31
JP4094667B2 (ja) 2008-06-04
CA2243650A1 (en) 1997-07-31
JP2000503977A (ja) 2000-04-04
WO1997027198A1 (en) 1997-07-31
CN1064683C (zh) 2001-04-18
AU1543797A (en) 1997-08-20
ES2180923T5 (es) 2005-10-16
DE69714971T3 (de) 2005-12-15
CA2243650C (en) 2006-08-15
KR19990081991A (ko) 1999-11-15
MX9805935A (es) 1998-11-30
ES2180923T3 (es) 2003-02-16
KR100491941B1 (ko) 2005-08-05
ATE222909T1 (de) 2002-09-15

Similar Documents

Publication Publication Date Title
DE69505190D1 (de) Verfahren zur Herstellung von hochreiner Essigsäure
ATE174903T1 (de) Neues verfahren zur herstellung von 7- (substituierten)-9-((substistuierter
DE69609907D1 (de) Verfahren zur Herstellung fehlerfreier Einkristalle mit grösserer Ausbringung
DE69104280D1 (de) Verfahren zur Herstellung von hochreiner Isophthalsäure.
DE69502336T2 (de) Verfahren zur Herstellung von Essigsäure
CA2244680A1 (en) Process for preparing purine derivatives
DE69119234T2 (de) Verfahren zur herstellung von reiner hydroxyessigsäure
DE69110590D1 (de) Verfahren zur Herstellung von Anilin von hoher Reinheit.
DE69101337T2 (de) Verfahren zur Herstellung von Anilin hoher Reinheit.
DE59402821D1 (de) Verfahren zur Herstellung flächiger kaschierter Teile unter Verwendung von Gitterförmigen Vorformlingen
ATE222909T1 (de) Verfahren zur herstellung von purin-derivaten
ATE305978T1 (de) Verfahren zur reinigung von s-adenosyl-l- methionin und zur herstellung von pharmazeutisch verträglichen salzen davon
DE69317820T2 (de) Verfahren zur Herstellung hochreiner Monoalkylphosphine
DE69105615D1 (de) Verfahren zur Herstellung von hochreiner Isophthalsäure.
ATE116636T1 (de) Verfahren zur herstellung von 2,6- dichlordiphenylaminessigsäurederivaten.
DE69424899T2 (de) Verfahren zur Herstellung von Essigsäure
DE69228226T2 (de) Verfahren zur Herstellung von 2-Amino-6-Halogenopurin und Synthese einer Zwischenverbindung
DE69204755D1 (de) Herstellung von Alkansulfonamiden.
DE69223156T2 (de) Verfahren zur herstellung von enantiomer reinem imidazo (4,5,1-jk) (1,4)-benzodiazepin-2(1h)-thionen
DE69002867D1 (de) Verfahren zur Herstellung hochreiner o-Toluolsäure.
DE69030399D1 (de) Verfahren zur Herstellung von 3-Exomethylencephamsulfoxydderivate und Zwischenverbindungen
DE69206070T2 (de) Verfahren zur Herstellung von Essigsäure.
IT8321645A0 (it) Processo per la produzione di acetato di etile per omolgazione di acetato di metile.
JPS6442489A (en) Method for crystallization and purification of 7-acylamidodeacetoxycephalosporanic acid
ATE35679T1 (de) Verfahren zur herstellung von cis-3,3,5trimethylcyclohexyl-d,l-alpha-(3-pyridincarboxy - phenylacetat.

Legal Events

Date Code Title Description
8363 Opposition against the patent
8366 Restricted maintained after opposition proceedings